Buffer Exchange Formulation Reduces Analyte Variability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Inter-sample variability in analyte measurements from biological samples poses a challenge for biomarker discovery, metabolic analyses, and diagnostic tools, particularly when small magnitude differences are critical, as it leads to inconsistent and unreliable datasets.

Innovation Solution

The method involves buffer exchange of biological samples using a formulation containing a buffering agent, salts, a chelating agent, and a nonionic surfactant to standardize protein concentrations, reducing variability and expanding the linear range of analyte measurements.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If buffer exchange is performed on biological samples, then inter-sample variability of analyte measurements is reduced and linear range of measurement is expanded, but the process complexity and time required for sample preparation increase

Engineering Contradiction:
Improveinter-sample variability of analyte measurementsVSAvoidsample preparation process complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The buffer exchange process is performed as a preliminary step before proteomic analysis to standardize sample conditions. By exchanging buffers in advance, the sample matrix is normalized to reduce inter-sample variability and expand linear measurement range, ensuring consistent results across different biological samples before the actual analysis begins

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A standardized buffer formulation acts as an intermediary medium during the buffer exchange process. This buffer contains specific components (buffering agent, salts, chelating agent, nonionic surfactant) that mediate the interaction between biological samples and the proteomic assay system, normalizing sample conditions and reducing matrix effects that cause variability

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If buffer exchange is performed on biological samples, then inter-sample variability of analyte measurements is reduced, but the time required for sample preparation increases

Engineering Contradiction:
Improveconsistency of analyte measurementsVSAvoidsample preparation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

Buffer exchange is performed as a preliminary standardized procedure to ensure reliable and consistent analyte measurements across all samples. By completing this normalization step before analysis, the method prevents variability issues during measurement, thereby improving reliability despite the additional time investment in sample preparation

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The buffer exchange process changes key parameters of the sample matrix, including pH, ionic strength, and buffer composition, to standardized values. This parameter normalization reduces inter-sample variability and improves measurement reliability, with the time cost justified by the significant improvement in data consistency

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces inter-sample variability and extends the linear range of analyte concentrations, resulting in more reliable and consistent measurements for proteins in biological samples.

Implementation Method 1

performing a buffer exchange on the biological sample using a formulation comprising a buffering agent, one or more salts, a chelating agent and a nonionic surfactant

Methodology Applied
Scientific EffectBuffer exchange:

Implementation Method 2

a formulation comprising a buffering agent, one or more salts, a chelating agent and a nonionic surfactant

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Implementation Method 3

a formulation comprising a buffering agent, one or more salts, a chelating agent and a nonionic surfactant

Methodology Applied
Scientific EffectChelation:

Data Source

PatentUS20220178940A1Reducing Intersample Analyte Variability in Complex Biological Matrices
Publication Date: 2022.06.09 SOMALOGIC OPERATING CO INC
  • US20220178940A1 patent drawing
  • US20220178940A1 patent drawing
  • US20220178940A1 patent drawing

AI summary

Described herein are compositions and methods for reducing the variability of inter-sample analyte measurements from a biological matrix. In some embodiments, the present disclosure relates to methods for reducing the variability in the inter-sample levels of one or more proteins from a biological sample as measured by a proteomic assay.